On June 1, 2023, the National Cancer Institute (NCI), a subset of the NIH, launched ComboMATCH, a precision medicine initiative for cancer patients. ComboMATCH — short for Combination Therapy...
The NIH’s National Institute of Allergy and Infectious Disease (NIAID) Vaccine Research Center (VCR) researchers have begun phase 1 clinical trials on a universal mRNA influenza vaccine. The...
An analysis of the impact of the National Institutes of Health (NIH) funding requirements determined that they improve diversity in medical scientist training programs (MSTPs). The data revealed more...
In a recent NIH press release, the organization announced a new study published in Nature Communications analyzing the safety and immunogenicity of a new temperature-stable tuberculosis (TB) vaccine....
In a recent research letter published in JAMA Network Open, Chris A. Rees, MD, MPH, and his colleagues analyzed how pediatric clinical trial results are disseminated or made publicly available. Rees...
An ongoing study supported by the NIH in San Francisco assessed the efficacy of long-acting antiretroviral therapy (LA-ART), administered via injection, for treating HIV. The study compared LA-ART to...
Despite having a high risk of failure, the clinical trial process can cost millions of dollars to complete. For clinical research organizations and sponsors, a clinical trial budget is critical in determining whether a clinical trial is...
A recent National Center for Health Statistics (NCHS) analysis determined that 18.4% of adults in the United States took a sleep medication to fall or stay asleep in the past 30 days. The study...
In House Bill 1047 — introduced on January 9, 2023, and sponsored by representative Sharlett Mena — Washington state has begun to take regulatory steps toward non-toxic cosmetics. The bill...
As public health officials become increasingly concerned about potential pandemic pathogen (PPP) research, the NIH has published a draft recommendation to guide future research policies and practices....
On October 17, 2022, the FDA announced that its Orphan Products Grants Program has awarded 19 grants and 2 contracts, amounting to over $38 million, for rare disease research. This action will...
In an announcement published by the FDA on October 21, 2022, Unilever North America — a New Jersey-based cosmetics company — voluntarily recalled multiple dry shampoo aerosol products...
Gonorrhea is one of the most common bacterial infections and is the third most common sexually transmitted infection (STI) in the United States. In an effort to mitigate disease spread, the NIH’s...
In a recent press release, Ro — a healthcare company — announced that it will partner with the National Institute of Aging, a subset of the NIH, to use its telehealth platform to diversify...
Bridge to Artificial Intelligence (Bridge2AI) is an NIH Common Fund Program focused on combining machine learning and artificial intelligence to provide advancements in the biomedical industry. According to a market analysis report done by...
On August 25, 2022, the Biden administration announced its plans to ensure equitable access to research. Outlined in the press release are the administration’s intentions to make all federally funded research free and accessible by...
Earlier this week, the FDA and NIH announced their launch of a public–private partnership for research on rare neurodegenerative diseases. The partnership, called the Critical Path for Rare...
The Advanced Research Projects Agency for Health (ARPA-H) was proposed by the Biden Administration on March 15, 2022, as a government organization to drive biomedical and healthcare innovation. Under...
Wearable devices have gained much traction recently for their potential uses in the healthcare industry. Recently, Northwestern University has collaborated with Johns Hopkins University on a research...
Chemotherapy drugs play a significant role in the treatment of cancer. Understanding the kinds of chemotherapy drugs can help patients make an informed decision with the assistance of their oncologist and their team of healthcare...
